arrow
T

Thomas S. Dexheimer

national institutes of health (nih) - usa
H指数:39
被引数:4,896

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types

RAS通路抑制剂与靶向药物联用对携带致癌性KRAS变异的多种癌症来源的类器官球体有效

2025-10-010
OAAI
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids

RNA加工激酶抑制剂和表观遗传抑制剂与肿瘤学药物或试验性药物联用,用于多细胞类型患者来源的肿瘤细胞球体

2025-09-120
OA
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource
2023-08-075
OAAI
Biochemical inhibition profiles of 370 wild type human kinases provide a basis for selecting alternative combinations of EGFR and VEGFR inhibitors
2023-04-040
PRE
Combination therapies in matched 3D in vitro and in vivo preclinical models of rare and recalcitrant cancers from the National Cancer Institute's Patient-Derived Models Repository
2023-04-040
PRE
Advancing a screening platform with panels of patient-derived organoid models for drug discovery and development
2023-04-040
PRE